U.S. regulators OK first new Alzheimer’s drug in nearly 20 years, against the advice of their own outside experts

More Articles:

• August 25

  Black Hills Corp. and NorthWestern Energy Announce All-Stock Merger

• August 27

  Gianforte Welcomes Semiconductor Firm to Montana

• August 30

  Knudsen Leads 23-State Coalition Urging EPA to Stop Funding Climate Advocacy Group

• August 25

  Montana Commerce Department Launches New Loan Program for Rural Businesses

• August 30

  Wall Street Ends August on Cautious Note

• Seattle PD prepping for potential protests over Christian concert at Gas Works Park